Rofecoxib (Vioxx) has been withdrawn, what next?
Idänpään-Heikkilä, J.E.; Klaukka, T.
Duodecim; Laaketieteellinen Aikakauskirja 120(21): 2489-2490
2004
ISSN/ISBN: 0012-7183 PMID: 15631403 Document Number: 567100
Document emailed within 1 workday
Related Documents
Scheen, A.J. 2000: Pharma-clinics. The drug of the month. Rofecoxib (Vioxx) Revue Medicale de Liege 55(7): 751-753Hawker, G.A.; Katz, J.N.; Solomon, D.H. 2006: The patient's perspective on the recall of Vioxx Journal of Rheumatology 33(6): 1082-1088
Jerie, P. 2005: VIOXX written off--and what next? COX-2 inhibitors and cardiovascular diseases Casopis Lekaru Ceskych 144(1): 4
Lampton, L. 2004: Vioxx, pharmacovigilance, flu vaccine, and the "prepared mind" Journal of the Mississippi State Medical Association 45(11): 333-335
Brune, K.; Zacher, J. 2004: Cardiovascular risk: a class effect of coxibs? how to manage patients taking Vioxx? MMW Fortschritte der Medizin 146(42): 10; 12
Martínez, J.ín.A.ón.; Tejada González, P.; Gutiérrez Sanpedro, N.; González Blanco, P. 2002: Gynecomastia secondary to rofecoxib Medicina Clinica 118(20): 798-799
1999: Tolcapone withdrawn Prescrire international 8(40): 53
de La Serna Higuera, C.; Rodríguez-Gómez, S.J.; Martín Arribas, M.I.; Martínez Moreno, J. 2002: Rofecoxib-induced upper gastrointestinal bleeding Medicina Clinica 118(6): 238; Author Reply 239
Livingston, M.G. 1990: Patients withdrawn from benzodiazepines Bmj 300(6739): 1588
Morović-Vergles, J. 2003: Rofecoxib: its efficacy in rheumatoid arthritis and acute pain Reumatizam 50(2): 47-48
Déciga-Campos, M.; Díaz-Reval, M.ía.I.; Ventura-Martínez, R.; López-Muñoz, F.J. 2004: Participation of the serotonin system in rofecoxib-induced antinociception Proceedings of the Western Pharmacology Society 47: 100-102
Gloyd, J.S. 1990: Insect repellents withdrawn from market Journal of the American Veterinary Medical Association 197(1): 25
Königová, R. 1996: Do-not-resuscitate orders and withheld or withdrawn treatment Acta Chirurgiae Plasticae 38(2): 73-77
Dyer, C. 2014: UK doctor who worked in US after being struck off by GMC has licence withdrawn Bmj 348: G1613
Frelick, R.W. 1989: Aspects of the dilemma: when and how should treatment be withheld or withdrawn? Delaware Medical Journal 61(6): 305-307
Hastings, G.B.; Ryan, H.; Teer, P.; MacKintosh, A.M. 1994: Cigarette advertising and children's smoking: why Reg was withdrawn Bmj 309(6959): 933-937
Wise, J. 1997: When life saving treatment should be withdrawn in children Bmj 315(7112): 834
Khan, F.Y.; Hassan, I.F.; Allity, M.H.; Khan, S.M. 2005: Retroperitoneal hematoma following rofecoxib and enoxaparin coadministration in a patient with atrial fibrillation Saudi Medical Journal 26(2): 336-337
Homoncik, M.; Malec, M.; Marsik, C.; Sycha, T.; Anzenhofer, S.; Gustorff, B.; Jilma, B. 2003: Rofecoxib exerts no effect on platelet plug formation in healthy volunteers Clinical and Experimental Rheumatology 21(2): 229-231
Schmutz, J-L.; Barbaud, A.; Trechot, P. 2003: Rofecoxib-induced aquagenic edema with puckering of the palms of the hands: the first case Annales de Dermatologie et de Venereologie 130(8-9 Pt 1): 813